阳谷华泰: 关于本次交易方案调整不构成重大调整的公告

Core Viewpoint - The company, Shandong Yanggu Huatai Chemical Co., Ltd., is adjusting its asset acquisition and fundraising plan, which involves changes in the transaction structure and the percentage of equity being acquired in the target company, Bomi Technology Co., Ltd. [1][2] Group 1: Transaction Adjustments - The company has revised its acquisition of Bomi Technology Co., Ltd. from 100% to 99.64% of the equity [1] - The transaction price has been adjusted from 144,304.25 million yuan to 143,790.84 million yuan [1] - The adjustments do not constitute a major change to the restructuring plan as per relevant regulations [2][3] Group 2: Decision-Making Process - The adjustments were approved during the 11th meeting of the 6th Board of Directors and the 8th meeting of the 6th Supervisory Board held on June 27, 2025, and further adjustments were approved in the 12th meeting on August 13, 2025 [1][3] - Prior to the board's review, an independent director meeting was held to assess the related proposals, which received approval [3] Group 3: Independent Financial Advisor's Opinion - The independent financial advisor, Zhongtai Securities Co., Ltd., confirmed that the adjustments do not constitute a major change to the restructuring plan according to the relevant regulations [3]